查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190571

诊断影像市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Diagnostic Imaging Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内（2022 年至 2027 年），诊断影像市场的复合年增长率将接近 6.1%。

预计 COVID-19 大流行将对市场产生重大影响。 根据 2020 年 11 月在 European Radiology 上发表的文章“入院胸片预测住院 COVID-19 患者的早期插管”，胸片有助于识别可能迅速恶化的 COVID-19 患者，以帮助告知临床管理和医院病床和通风分配。 这将增加该设备在医院 COVID 病房中的使用。 2020 年 4 月，德国伦琴学会 (DRG) 发布了在 COVID-19 患者中使用 CT 扫描的指南。 根据 DRG，对于初始 PCR 和临床结果为阴性的有临床症状的患者，建议对 COVID-19 进行诊断性 CT 扫描。 还建议通过顺序逆转录 PCR (RT-PCR) 确认 CT 结果。 同样，2020 年 4 月，英国启动了国家 COVID-19 胸部影像数据库 (NCCID)，该数据库提供了对 COVID-19 的更全面了解，以及来自该国 20 个 NHS 信託机构的 X 射线、CT 和 MRI 扫描。我们正在整理数据并使用人工智能 (AI) 来检测疾病模式和病毒标记，从而实现更准确的早期诊断和预后，并为新疗法提供信息。 预计这将在 COVID-19 大流行期间增加对此类设备和测试的需求。 产品发布也是市场增长的原因之一。 例如，2020 年 11 月，皇家飞利浦为放射科医生推出了“飞利浦高级可视化工作空间-IntelliSpace Portal 12”。 IntelliSpace Portal 现在配备了人工智能驱动的定量评估和自动结果生成功能，以支持诊断工作流程，包括心脏病学、肺病学、肿瘤学和神经病学的随访和交流。 其 AI 辅助肺功能还包括评估与 COVID-19相关的复杂肺部疾病。

推动诊断影像市场增长的主要因素包括慢性病患病率上升、先进医学影像技术的采用率增加以及老年人口增加。

全球慢性病负担日益加重，影像学诊断在慢性病的准确诊断中发挥着重要作用。 老龄化社会的到来和社会行为的改变导致这些常见且代价高昂的长期健康问题稳步增加。 许多慢性病死亡归因于癌症、心血管疾病、肥胖症和糖尿病。 据 GLOBOCAN 称，2020 年全球将报告约 1930 万例新癌症病例，预计到 2040 年这一数字将增至 3020 万例。 新兴市场将受到最大影响，因为人口增长预计将在发展中地区最为明显。

正在开发新的治疗和诊断模型，以提供准确的结果，帮助及早发现疾病，并最大限度地降低治疗这些疾病的成本。 随着可支配收入的增加，人们越来越多地使用成像方式来早期发现疾病。

在数字和通信技术进步的推动下，医学成像领域正在以非常快的速度发展。 大多数诊断实验室和医院都可以使用揭示解剖细节的新成像技术。 目标是提高访问和准确性，降低成本，并使其免受辐射和有害。 趋势是从固定设备转向便携式设备。 例如，直到最近，尺寸和功率要求还阻碍了超声波的正确使用。 小型超声系统可以完全依靠电池供电进行彩色血流多普勒成像。

诊断影像设备的市场趋势

预计在预测期内中端 CT 扫描仪（约 64 层）将占据最大的市场份额

由于 COVID-19 的爆发，计算机断层扫描 (CT) 扫描仪在市场上经历了巨大的增长。 公司已采取一些明确的步骤来满足全球对扫描仪不断增长的需求。 例如，2020 年 2 月，三星 NeuroLogica 在 COVID-19 病例激增的情况下加紧生产 32 层 CT 扫描仪“mobile BodyTom”。 它的内部屏蔽设计允许在护理点对 COVID-19 患者进行扫描，同时最大限度地减少接触病毒的机会。 因此，COVID-19的出现有望提振市场。

与低端 CT 扫描仪相比，中端 CT 扫描仪更适合血管造影。 它的高速和灵敏性使医疗保健专业人员能够查看动脉壁的斑块形成、查看最小的血管和动脉分支，并且适用于心臟检查。

公司不断开发新产品以增加其在市场上的影响力。 例如，2020年1月，Arranger与佳能医疗系统公司共同推出了新型CT扫描仪“ACUTOM 32”。 该扫描仪是一款 32 层 CT 扫描仪，具有 32 厘米宽的孔门架、大约 2.0 MHU 的 X 射线管和大约 0.75 秒的旋转时间。 同样在 2022 年 1 月，佩里港医院保健中心 (PPHF) 超额完成了筹集 400 万美元的目标，用于在 Skagog 保健中心安装 CT 扫描仪和其他关键设备。

因此，预计这些 CT 扫描仪的产品发布数量将增加，从而使市场增长更加繁荣。

北美占全球市场份额最大

北美占诊断影像市场的主要份额，预计在预测期内将呈现类似的趋势，不会出现重大波动。 由于 COVID-19 的爆发，预计还将观察到对研究市场的深远影响。 代表美国近 40,000 名放射科医师的美国放射学会 (ACR) 表示，COVID-19 具有极强的传染性，因此应将 CT 和 X 射线用作一线诊断和筛查工具。我们已发布指南，指出它不是。

美国在诊断影像市场占有很大份额，据认为 2020 年 10 月，Siemens Healthmeyers 的 Ysio Max 数字放射成像系统获得 FDA 批准，该系统具有新的检测器和可用性功能，可改善成像和速度检查。。

此外，由于发达的医疗机构的存在、人口老龄化对先进医疗系统的需求增加以及慢性病的增加，预计在预测期内市场将扩大。 预计脑肿瘤等神经系统疾病患病率的上升也将推动市场增长。 据美国脑肿瘤协会称，2020 年美国将有 70 万人患有脑肿瘤，约有 87,000 人将被诊断出患有脑肿瘤。 因此，预计上述因素将在预测期内推动同一地区的市场。

影像诊断市场竞争分析

市场是分散的，因为市场上有多家公司。 主要参与者包括 Siemen Healthineers、Koninklijke Philips NV、GE Healthcare、Hologic Corporation 和 Mindray Medical International Limited。 市场参与者专注于研发以开发技术先进的产品，以降低与产品相关的成本和副□□作用。 由于该行业的进入壁垒高，一些大公司占据了最大的市场份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 慢性病增加
    • 在医学成像领域更多地采用先进技术
    • 老年人口增加
  • 市场製约因素
    • 昂贵的程序和设备
    • 诊断成像的副作用
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按方式
    • 核磁共振
      • 低/中磁场 MRI 设备（小于 1.5T）
      • 高场 MRI 系统 (1.5-3T)
      • 超高磁场/超高磁场核磁共振设备（3T以上）
    • 计算机断层扫描
      • 低端扫描仪（~16-Slice）
      • 中端扫描仪（约 64 片）
      • 高端扫描仪（128 层或更多）
    • 超声诊断设备
      • 二维超声
      • 3D 超声
      • 其他超声波
    • X光
      • 模拟
      • 数字
    • 核医学成像
      • 正电子发射断层扫描 (PET)
      • 单光子发射计算机断层扫描 (SPECT)
    • 透视设备
    • 乳腺摄影
  • 通过使用
    • 心脏病学
    • 肿瘤科
    • 神经病学
    • 骨科
    • 胃肠病学
    • 妇科
    • 其他用途
  • 最终用户
    • 医院
    • 诊断中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Canon Medical Systems Corporation
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE Healthcare
    • Hologic Corporation
    • Koninklijke Philips NV
    • Shimadzu Medical
    • Siemens Healthineers
    • Mindray Medical International Limited
    • Browns Medical Imaging（BMI）
    • Samsung Electronics Co. Ltd
    • Koning Corporation

第7章 市场机会与今后动向

简介目录
Product Code: 57005

The Diagnostic Imaging Market is expected to register a CAGR of nearly 6.1% during the forecast period (2022-2027).

The COVID-19 pandemic is expected to have a significant impact on the market. According to an article titled, Chest radiograph at admission predicts early intubation among inpatient COVID-19 patients appearing in European Radiology in November 2020, chest radiography was useful in identifying COVID-19 patients who may rapidly deteriorate and help inform clinical management and a hospital bed and ventilation allocation. This is likely to increase the usage of these devices in COVID wards of hospitals. In April 2020, the German Rontgen Society (DRG) issued a guideline for using CT scans for COVID-19 patients. According to the DRG, for a clinically symptomatic patient, with initially negative PCR and clinical consequences, a CT scan is recommended to help diagnose COVID-19. It is also recommended to confirm the CT finding by sequential reverse transcription PCRs (RT-PCRs) tests. Similarly, in April 2020, the National COVID-19 Chest Imaging Database (NCCID) was launched in United Kingdom that provides a more comprehensive understanding of COVID-19, collating X-Rays, CT, and MRI scan data from 20 NHS trusts across the country to detect disease patterns and markers of the virus using Artificial Intelligence (AI), which, in turn, enables more accurate early diagnoses and prognoses and inform new treatments. This is expected to boost the demand for such equipment and tests during the COVID-19 pandemic. Product launches are another reason for the growth of the market. For instance, in November 2020, Royal Philips launched the Philips Advanced Visualization Workspace - IntelliSpace Portal 12 for radiologists. The IntelliSpace Portal features a robust set of new AI-assisted quantitative assessment and automatic results generation features to support the diagnostic workflow, including follow-up and communication across cardiology, pulmonology, oncology, and neurology. Its AI-assisted pulmonary capabilities include the assessment of complex lung conditions associated with COVID-19.

The major factors augmenting the growth of the diagnostic imaging market include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and a rise in the geriatric population.

The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases. The increase in the aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. Most of the deaths by chronic diseases are attributable to cancer, cardiovascular diseases, obesity, and diabetes. According to GLOBOCAN, in 2020, about 19.3 million new cases of cancer were reported worldwide, and this number is expected to increase to 30.2 million in 2040. The most affected would be the emerging markets, as the population growth is anticipated to be most significant in developing areas.

New models for therapy and diagnoses are being developed, which provide precise results, help in the early detection of diseases, and help minimize the cost of treating these diseases. With the increasing disposable income, people are becoming capable enough to have access to imaging procedures for the early detection of diseases.

The medical imaging field has advanced at a great pace, stimulated by advances in digital and communication technologies. New imaging techniques that reveal greater anatomical details are available in most diagnostic labs and hospitals. The aim is to improve access and precision, decrease cost, and make the impact of radiationless harmful. The trend is shifting from fixed to portable equipment. For example, until recently, size and electricity requirements have hindered the proper use of ultrasound. Smaller ultrasound equipment can provide color-flow Doppler imaging, relying on battery power solely.

Diagnostic Imaging Market Trends

Mid-range Scanners (~64-Slice) Segment under Computed Tomography expected to Account for Largest Market Share during the Forecast Period

The computed tomography (CT) scanners experienced tremendous growth in the market studied due to the outbreak of COVID-19. Companies took several definite measures in order to keep up with the growing demand for scanners all over the world. For instance, in February 2020, with the rapidly growing COVID-19 cases, Samsung NeuroLogica ramped up the production of its 32-slice CT scanner, mobile BodyTom. It allows scanning of COVID-19 patients at the point of care due to its internal shielded design and, at the same time, minimizes exposure to the virus. Hence, owing to such instances, the market is expected to boost with the emergence of COVID-19.

Mid-range CT scanners are better for performing angiography in comparison with low-range CT scanners. Its characteristics, such as high speed and sensitivity, allow healthcare professionals to view the walls of arteries for plaque formation and to observe the tiniest of vessels and arterial branches and therefore are well suited for cardiac studies.

In order to grow their presence in the market, companies are continuously engaged in the development of new products. For instance, in January 2020, Allengers, in collaboration with Canon Medical Systems Corporation, introduced a new CT scanner in the market, ACUTOM 32, which is a 32 slice CT scanner featured with wide bore gantry of 32 cm, about 2.0MHU X-ray tube, and about 0.75 seconds of rotation time. Similarly, in January 2022, the Port Perry Hospital Foundation (PPHF) surpassed its goal of raising USD 4 million to bring a CT scanner and other essential equipment to the Scugog healthcare center.

Thus, rising product launches of these CT scanners are further expected to flourish the market growth.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share of the diagnostic imaging market and is expected to show a similar trend over the forecast period, without significant fluctuations. Due to the outbreak of COVID-19, a profound impact on the market studied is also expected to observe. The American College of Radiology (ACR), which represents nearly 40,000 radiologists in United States, issued guidance that CTs and X-rays should not be used as a first-line tool to diagnose or screen for COVID-19, as it is highly contagious.

United States contributes the major share in the diagnostic imaging market, which can be attributed to the increasing technological advances, higher affordability rates from the population, and the number of diagnostic procedures increasing on a yearly basis. In October 2020, Siemens Healthineers received clearance from the FDA for the Ysio Max digital radiography system, which includes new detectors and usability features that improve imaging and quicken exams.

Also, with the presence of well-established healthcare facilities, increasing demand for advanced healthcare systems among the aging population, and increasing prevalence of chronic diseases, the market is expected to grow in the forecast period. The growing number of neurological disorders such as brain tumors is also expected to propel market growth. As per the National Brain Tumor Society, in 2020, 700,000 people in United States are living with a brain tumor and around 87,000 as expected to be diagnosed with a brain tumor. Thus, with the aforementioned factors, the market is expected to propel in this region during the forecast period.

Diagnostic Imaging Market Competitive Analysis

The market studied is fragmented owing to the presence of several players in the market. Some of the major players in the market include Siemen Healthineers, Koninklijke Philips NV, GE Healthcare, Hologic Corporation, and Mindray Medical International Limited. The market players are focusing on R&D to develop technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition​
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Prevalence of Chronic Diseases
    • 4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
    • 4.2.3 Increase in the Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures and Equipment
    • 4.3.2 Side Effects of Diagnostic Imaging
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Modality
    • 5.1.1 MRI
      • 5.1.1.1 Low and mid field MRI Systems (less than 1.5 T)
      • 5.1.1.2 High field MRI Systems (1.5-3 T)
      • 5.1.1.3 Very High and Ultra High Field MRI Systems (3T and more)
    • 5.1.2 Computed Tomography
      • 5.1.2.1 Low-end Scanners (~16-Slice)
      • 5.1.2.2 Mid-range Scanners (~64-Slice)
      • 5.1.2.3 High-end Scanners (128-Slice and More)
    • 5.1.3 Ultrasound
      • 5.1.3.1 2D Ultrasound
      • 5.1.3.2 3D Ultrasound
      • 5.1.3.3 Other Ultrasound
    • 5.1.4 X-Ray
      • 5.1.4.1 Analog Systems
      • 5.1.4.2 Digital Systems
    • 5.1.5 Nuclear Imaging
      • 5.1.5.1 Positron Emission Tomography (PET)
      • 5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
    • 5.1.6 Fluoroscopy
    • 5.1.7 Mammography
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Orthopedics
    • 5.2.5 Gastroenterology
    • 5.2.6 Gynecology
    • 5.2.7 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Esaote SpA
    • 6.1.3 FUJIFILM Holdings Corporation
    • 6.1.4 GE Healthcare
    • 6.1.5 Hologic Corporation
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Shimadzu Medical
    • 6.1.8 Siemens Healthineers
    • 6.1.9 Mindray Medical International Limited
    • 6.1.10 Browns Medical Imaging (BMI)
    • 6.1.11 Samsung Electronics Co. Ltd
    • 6.1.12 Koning Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS